Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Warrants (Schedule Of Unrealized Gain/(Loss) On Fair Value Of Warrants) (Details)

Warrants (Schedule Of Unrealized Gain/(Loss) On Fair Value Of Warrants) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	$ 967,637	$ 608,301	$ 3,941,682	$ 2,282,476
Expired Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants		(9,903)	2,590	384,365
December 2012 Investor Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	2,212	16,350	9,490	46,021
July 2013 Investor Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	22,040	147,848	115,940	412,208
October 2013 Investor Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	30,264	166,744	159,871	472,682
January 2014 Investor Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	12,190	$ 287,262	129,905	$ 967,200
November 2015 Investor Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	409,125		1,613,750
November 2015 Placement Agent Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	24,683		104,842
March 2016 Investor Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	425,625		1,677,891
March 2016 Placement Agent Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	26,283		112,188
September 2016 Investor Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	12,780		12,780
September 2016 Placement Agent Warrants [Member]
Class of Warrant or Right [Line Items]
Unrealized gain on fair value of warrants	$ 2,435		$ 2,435